Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND‐IA Trials and a Pooled International Cohort
Authors: Sarraj Amrou , Albers Gregory W. , Blasco Jordi , Arenillas Juan F. , Ribo Marc , Hassan Ameer E. , de la Ossa Natalia Pérez , Wu Teddy Yuan‐Hao , Cardona Portela Pere , Abraham Michael G. , Chen Michael , Maali Laith , Kleinig Timothy J. , Cordato Dennis , Wallace Adam Nathan , Schaafsma Joanna D. , Sangha Navdeep , Gibson Daniel P. , Blackburn Spiros L. , De Lera Alfonso Mercedes , Pujara Deep , Shaker Faris , McCullough‐Hicks Margy E. , Moreno Negrete Javier Luis , Renu Arturo , Beharry James , Cappelen‐Smith Cecilia , Rodríguez‐Esparragoza Luis , Olivé‐Gadea Marta , Requena Manuel , Almaghrabi Tareq , Mendes Pereira Vitor , Sitton Clark , Martin‐Schild Sheryl , Song Sarah , Ma Henry , Churilov Leonid , Mitchell Peter J. , Parsons Mark W. , Furlan Anthony , Grotta James C. , Donnan Geoffrey A. , Davis Stephen M. , Campbell Bruce C. V. ,   for the PERFECT‐MILD Collaborators
Published: May 2022

ObjectiveThis study was undertaken to evaluate functional and safety outcomes for endovascular thrombectomy (EVT) versus medical management (MM) in patients with large vessel occlusion (LVO) and mild neurological deficits, stratified by perfusion imaging mismatch.MethodsThe pooled cohort consisted of patients with National Institutes of Health Stroke Scale (NIHSS) < 6 and internal carotid artery (ICA), M1, or M2 occlusions from the Extending the Time for Thrombolysis in Emergecy Neurological Deficits ‐ Intra‐Arterial (EXTEND‐IA) Trial, Tenecteplase vs Alteplase before Endovascular Thrombectomy in Ischemic Stroke (EXTEND‐IA TNK) trials Part I/II and prospective data from 15 EVT centers from October 2010 to April 2020. RAPID software estimated ischemic core and mismatch. Patients receiving primary EVT (EVTpri) were compared to those who received primary MM (MMpri), including those who deteriorated and received rescue EVT, in overall and propensity score (PS)‐matched cohorts. Patients were stratified by target mismatch (mismatch ratio ≥ 1.8 and mismatch volume ≥ 15ml). Primary outcome was functional independence (90‐day modified Rankin Scale = 0–2). Secondary outcomes included safety (symptomatic intracerebral hemorrhage [sICH], neurological worsening, and mortality).ResultsOf 540 patients, 286 (53%) received EVTpri and demonstrated larger critically hypoperfused tissue (Tmax > 6 seconds) volumes (median [IQR]: 64 [26–96] ml vs MMpri: 40 [14–76] ml, p < 0.001) and higher presentation NIHSS (median [IQR]: 4 [2–5] vs MMpri: 3 [2–4], p < 0.001). Functional independence was similar (EVTpri: 77.4% vs MMpri: 75.6%, adjusted odds ratio [aOR] = 1.29, 95% confidence interval [CI] = 0.82–2.03, p = 0.27). EVT had worse safety regarding sICH (EVTpri: 16.3% vs MMpri: 1.3%, p < 0.001) and neurological worsening (EVTpri: 19.6% vs MMpri: 6.7%, p < 0.001). In 414 subjects (76.7%) with target mismatch, EVT was associated with improved functional independence (EVTpri: 77.4% vs MMpri: 72.7%, aOR = 1.68, 95% CI = 1.01–2.81, p = 0.048), whereas there was a trend toward less favorable outcomes with primary EVT (EVTpri: 77.4% vs MMpri: 83.3%, aOR = 0.39, 95% CI = 0.12–1.34, p = 0.13) without target mismatch (pinteraction = 0.06). Similar findings were observed in a propensity score‐matched subpopulation.InterpretationOverall, EVT was not associated with improved clinical outcomes in mild strokes due to LVO, and sICH was increased. However, in patients with target mismatch profile, EVT was associated with increased functional independence. Perfusion imaging may be helpful to select mild stroke patients for EVT. ANN NEUROL 2022;92:364–378